TrialBreast cancer research and treatment2012

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer.

A J Montero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.